RFP | March 27, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2) Grant. The purpose of this grant is to support early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact for this program . . .